Ryota Hosoya

470 total citations
19 papers, 166 citations indexed

About

Ryota Hosoya is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ryota Hosoya has authored 19 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Hematology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ryota Hosoya's work include Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (2 papers). Ryota Hosoya is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (2 papers). Ryota Hosoya collaborates with scholars based in Japan, Cambodia and Singapore. Ryota Hosoya's co-authors include Atsushi Manabe, Hiroshi Matsufuji, Chitose Ogawa, Daisuke Hasegawa, Takahiro Kamiya, Kenichi Yoshida, K Sugita, S Nakazawa, Takahiro Mori and Shuki Mizutani and has published in prestigious journals such as PEDIATRICS, Leukemia and Journal of Neurology.

In The Last Decade

Ryota Hosoya

19 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryota Hosoya Japan 9 57 56 35 30 29 19 166
Corinne Armari‐Alla France 8 82 1.4× 52 0.9× 74 2.1× 58 1.9× 31 1.1× 14 229
Т. Т. Валиев Russia 6 33 0.6× 59 1.1× 37 1.1× 19 0.6× 12 0.4× 119 155
Kyung Taek Hong South Korea 8 54 0.9× 23 0.4× 27 0.8× 17 0.6× 20 0.7× 54 165
Anna Pieczonka Poland 9 107 1.9× 60 1.1× 45 1.3× 10 0.3× 15 0.5× 31 202
Rajni Agarwal‐Hashmi United States 5 76 1.3× 44 0.8× 26 0.7× 11 0.4× 9 0.3× 11 155
Sidharth Totadri India 9 82 1.4× 74 1.3× 85 2.4× 50 1.7× 17 0.6× 41 254
Milena La Spina Italy 9 36 0.6× 26 0.5× 22 0.6× 11 0.4× 60 2.1× 27 194
J Cubells Spain 11 159 2.8× 100 1.8× 70 2.0× 57 1.9× 13 0.4× 22 279
Jiaoyang Cai China 9 45 0.8× 67 1.2× 73 2.1× 42 1.4× 10 0.3× 32 188
Marie-Émilie Dourthe France 6 26 0.5× 35 0.6× 35 1.0× 10 0.3× 19 0.7× 27 135

Countries citing papers authored by Ryota Hosoya

Since Specialization
Citations

This map shows the geographic impact of Ryota Hosoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Hosoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Hosoya more than expected).

Fields of papers citing papers by Ryota Hosoya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Hosoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Hosoya. The network helps show where Ryota Hosoya may publish in the future.

Co-authorship network of co-authors of Ryota Hosoya

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Hosoya. A scholar is included among the top collaborators of Ryota Hosoya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Hosoya. Ryota Hosoya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yoshihara, Hiroki, Takahiro Kamiya, Daisuke Hasegawa, et al.. (2016). Ewing sarcoma/primitive neuroectodermal tumor of the kidney treated with chemotherapy including ifosfamide. Pediatrics International. 58(8). 766–769. 2 indexed citations
2.
Ono, Rintaro, Daisuke Hasegawa, Shinsuke Hirabayashi, et al.. (2014). Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children. European Journal of Pediatrics. 174(4). 525–531. 19 indexed citations
3.
Yamamoto, Naomasa, Noriko Akamatsu, Hitoshi Sakuraba, et al.. (2013). Novel Bernard-Soulier syndrome variants caused by compound heterozygous mutations (case I) or a cytoplasmic tail truncation (case II) of GPIbα. Thrombosis Research. 131(4). e160–e167. 3 indexed citations
4.
Nozaki, Taiki, et al.. (2013). Temporal Lobe Epilepsy With Hippocampal Sclerosis in Acute Lymphoblastic Leukemia. PEDIATRICS. 132(1). e252–e256. 7 indexed citations
5.
Kamiya, Takahiro, Daisuke Hasegawa, Chitose Ogawa, et al.. (2011). Intellectual development after treatment in children with acute leukemia and brain tumor. Pediatrics International. 53(5). 694–700. 8 indexed citations
6.
Yoshida, Kenichi, Daisuke Hasegawa, Itaru Kato, et al.. (2010). Bullous exudative retinal detachment due to infiltration of leukemic cells in a child with acute lymphoblastic leukemia. International Journal of Hematology. 92(3). 535–537. 9 indexed citations
7.
Hasegawa, Daisuke, Chitose Ogawa, Itaru Kato, et al.. (2009). Detection of submicroscopic disease in the bone marrow and unaffected testis of a child with T-cell acute lymphoblastic leukemia who experienced “isolated” testicular relapse. International Journal of Hematology. 90(3). 370–373. 3 indexed citations
8.
Ogawa, Chitose, Kenichi Yoshida, Shinsuke Hirabayashi, et al.. (2009). The ex vivo production of ammonia predicts l-asparaginase biological activity in children with acute lymphoblastic leukemia. International Journal of Hematology. 90(3). 347–352. 11 indexed citations
9.
Takahashi, Hiroka, Atsushi Manabe, Takahiro Kamiya, et al.. (2007). Iodine‐131‐metaiodobenzylguanidine therapy with reduced‐intensity allogeneic stem cell transplantation in recurrent neuroblastoma. Pediatric Blood & Cancer. 50(3). 676–678. 10 indexed citations
10.
Matsufuji, Hiroshi, et al.. (2006). Successful treatment for intractable chylous ascites in a child using a peritoneovenous shunt. Pediatric Surgery International. 22(5). 471–473. 20 indexed citations
11.
Hosoya, Ryota, et al.. (2002). Focusing on Posttraumatic Stress of Survivors of Childhood Cancer. 106(4). 464–471. 2 indexed citations
12.
Ma, Fen, Atsushi Manabe, Mamoru Ito, et al.. (2002). Growth of human T cell acute lymphoblastic leukemia lymphoblasts in NOD/SCID mouse fetal thymus organ culture. Leukemia. 16(8). 1541–1548. 6 indexed citations
13.
Manabe, Atsushi, et al.. (2000). Long-term remission induced by corticosteroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia. Medical and Pediatric Oncology. 34(3). 224–225. 5 indexed citations
14.
Manabe, Atsushi, Y Ebihara, Atsushi Saito, Keiso Takahashi, & Ryota Hosoya. (1997). [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].. PubMed. 38(8). 669–73. 2 indexed citations
15.
Ikawa, Hiroaki, et al.. (1995). The Role of Surgery in Advanced Neuroblastoma. European Journal of Pediatric Surgery. 5(1). 23–26. 9 indexed citations
16.
Mori, Takahiro, K Sugita, Toshio Suzuki, et al.. (1995). A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.. PubMed. 9(7). 1233–9. 28 indexed citations
17.
Hosoya, Ryota, et al.. (1991). Principles of Total Care for Children with Leukemia —Psychosocial Interventions —. Pediatrics International. 33(4). 589–594. 6 indexed citations
18.
Tomiwa, Kiyotaka, Harukí Mikawa, Fumitada Hazama, et al.. (1983). Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology. Journal of Neurology. 229(4). 267–272. 10 indexed citations
19.
Fujita, Yu, et al.. (1982). Clinical trial of plasmapheresis in hepatic failure.. PubMed. 28. 225–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026